AKUT PROMYELOSİTİK LÖSEMİ (APL) TEDAVİSİ

Kaynaklar:

1-Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, et al. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood. 2019 Apr 11. 133 (15):1630-1643

2-Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood. 1999 Aug 15. 94(4):1192-200.

3-Adès L, Chevret S, Raffoux E, et al. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. J Clin Oncol. 2006 Dec 20. 24(36):5703-10.

4-[Guideline] National Comprehensive Cancer Network Practice Guidelines: Acute Myeloid Leukemia. NCCN. Available at https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf. Version 1.2022 — December 2, 2021; Accessed: March 29, 2022.